# A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of VG2025 Intravenous Injection in Subjects With Advanced Solid Tumors

> clinical trial · VERIFIED · 2026-07-06

Status: NOT_YET_RECRUITING · Sponsor: Virogin Biotech Ltd. · Condition: Advanced Malignant Solid Tumor

- Company: Virogin Biotech Ltd.
- Sector: Advanced Malignant Solid Tumor
- Primary source: https://clinicaltrials.gov/study/NCT07682870

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.